Leukemia, Plasma Cell

Known as: Plasma Cell Leukemias, cells leukemia plasma, LEUKEMIA PLASMACYTIC 
An aggressive plasma cell neoplasm characterized by the presence of neoplastic plasma cells in the peripheral blood. It is characterized by the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
The longitudinal evolution of a myeloma genome from diagnosis to plasma cell leukemia has not previously been reported. We used… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Plasma cell leukemia (PCL) is an aggressive and rare hematological malignancy that originates either as primary disease (pPCL) or… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
In multiple myeloma (MM), the growth of primary plasma cells depends not only on interleukin-6 (IL-6), but also on additional… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
We report on a series of 26 patients diagnosed with primary (de novo) plasma cell (PC) leukemia (PCL) in whom we analyzed the… (More)
  • table 3
  • table 1
  • table 2
  • table 4
  • figure 2
Is this relevant?
Review
1999
Review
1999
Nonsecretory myeloma, which accounts for 1% to 5% of all myelomas, is characterized by the absence of detectable M-protein in… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Chromosome rearrangement of 14q32.33 has recurrently occurred with variable partner sites, including 11q13.3, 8q24.1, 18q21.3… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1991
Highly Cited
1991
A patient with primary plasma cell leukemia resistant to chemotherapy was treated for 2 months with daily intravenous injections… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Using a specific and very sensitive (1 pg = 1 U) bioassay, we investigated the presence of IL-6, a potent myeloma cell growth… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Chromosome studies were done on 82 patients with multiple myeloma, 11 with amyloidosis, 2 with multiple myeloma and amyloidosis… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?